The types of tests used to monitor health can be expensive. Alternative ways of assessing patient health and making decisions about treatment and care are an important aspect of health care in resource-limited settings. This can include taking a detailed patient history and performing a physical examination.

Health monitoring in resource-limited settings: latest news

Health monitoring in resource-limited settings resources

Health monitoring in resource-limited settings features

Health monitoring in resource-limited settings news from aidsmap

More news

Health monitoring in resource-limited settings news selected from other sources

  • HIV viral load testing capacities progress, require global support, multiple partners to reach 90-90-90 goals

    Four of seven sub-Saharan African countries followed by researchers over the last year and a half now can track the effectiveness of HIV treatment among all patients receiving it with tests to measure the levels of virus in their bodies at least once a year, according to an update in last week’s Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

    06 December 2016 | Science Speaks
  • HIV test performed on USB stick

    The device, created by scientists at Imperial College London and DNA Electronics, uses a drop of blood to detect HIV, and then creates an electrical signal that can be read by a computer, laptop or handheld device. The disposable test could be used for HIV patients to monitor their own treatment.

    11 November 2016 | Imperial College
  • Africa has an essential medicines list. Now it needs one for diagnostics

    An essential diagnostics list would detail diagnostic tests that should be available to people who need them. These could range from point-of-care tests in physicians’ offices or in pharmacies to high-complexity tests in reference laboratories. The end result would be a health system where people were more accurately diagnosed and treated, where disease outbreaks could be identified earlier, and diagnostic tests performed according to a high standard.

    27 October 2016 | The Conversation
  • HIV effort let down by test shortages, says WHO

    A shortage of HIV testing could undermine global efforts to diagnose and treat people with the infection, warn experts from the World Health Organization.

    24 August 2016 | BBC Health
  • Alere HIV Combo Test Receives WHO Prequalification

    Alere, a global leader in rapid diagnostics, today announced that its Alere HIV Combo, a rapid point-of-care fourth-generation test that detects both HIV-1/2 antibodies and the HIV-1 p24 antigen, has been awarded World Health Organization (WHO) prequalification, making it available for public sector procurement in resource-limited countries.

    17 July 2016 | Alere press release
  • Challenges Loom for Point-of-Care Diagnostics

    POC is likely to grow in emerging markets, where limited resources and local conditions make traditional lab-based testing less practical.

    13 July 2016 | Genetic Engineering & Biotechnology News
  • MSF Report - Making Viral Load Routine

    Based on a survey performed across ten MSF supported ART sites and seven viral load testing laboratories in February 2016, “Making viral load routine” aims to share practical lessons from the field with Ministries of Health and implementing partners. The report reflects both on the programmatic strategies required within the clinic (for clinicians, counsellors and patients) and the realities of both setting up and keeping a viral load testing laboratory functional in such settings.

    12 July 2016 | MSF
  • European prize for HIV diagnostic kit

    The device, called SAMBA, can accurately and rapidly diagnose HIV using a tiny sample of blood. The kits are used in countries with no laboratory infrastructure and they do not need to be operated by medically trained staff.

    12 June 2016 | Wellcome Trust
  • Abbott inks $5.8B deal for Alere to expand in point-of-care diagnostics

    Abbott has landed on its next purchase, snatching up diagnostics outfit Alere to bulk up in point-of-care diagnostics and expand its international reach.

    09 February 2016 | Fierce Medical Devices
  • HIV and drug resistance

    A recent study found more resistance to the antiretroviral medicine tenofovir than had previously been reported, with 20% resistance to tenofovir in patients with treatment failure in Europe and over 50% resistance in patients with treatment failure in sub-Saharan Africa... The study underlines the importance of rapidly identifying treatment failure through routine measurement of viral load suppression—this is the basis of the third pillar of UNAIDS’ 90–90–90 treatment target, that 90% of people accessing HIV treatment have suppressed viral loads.

    09 February 2016 | UNAIDS
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.